Skip to content
Forensic Analysis · Parts & Accessories Manufacturing · as of Nov 9, 2026

Dorman Products, Inc. (DORM)

A forensic read on Dorman Products, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective
Forensic grade
Safe
Financial health
6.8
Distress distance
Clean
Earnings quality
3
Forensic signals
14.7%
ROE
6.0%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Dorman Products, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 6.8, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by inventory days.

What the filings flag

247d
FY2024→FY2025
Inventory days. Days inventory outstanding moved from 204 to 247 FY2024→FY2025 (against cost of goods sold; inventory +35% vs +2% in cost of sales). Inventory is outrunning what's being sold — a flag for softening demand or obsolescence risk ahead.
$57M
FY2025
Goodwill impairments. Took $57M of goodwill writedowns across 1 year (FY2025 ($57M)) — about 28% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.
11.6%
FY2025
Return on invested capital. Return on invested capital is 11.6% in the latest fiscal year and rising across FY2023–FY2025 from 9.6%. After-tax operating profit was $165M in FY2023 and $222M in FY2025, with operating income at 11.1% of revenue in FY2023, 14.6% in FY2024 and 14.1% in FY2025. The capital base behind it grew +11% across FY2023–FY2025, from $1.7B to $1.9B, and the return did not fall doing it, so the dollars added over that window earned at least the 9.6% the older base was already earning.

Key fundamentals

Latest Revenue$2.13B
Revenue Growth YoY+6.0%
Revenue CAGR (2yr)+5.1%
Net Margin9.6%
Free Cash Flow$75.7M
Return on Equity14.7%
Debt / Equity0.30x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Dorman Products, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.